Dysregulation of the intestinal epithelial barrier in genetically
susceptible individuals may lead to both intestinal and extraintestinal
autoimmune disorders. There is emerging literature on
the role of microbiota changes in the pathogenesis of systemic
rheumatic diseases such as rheumatoid arthritis, spondyloarthropathies,
and connective tissue diseases. Although the role of
the gastrointestinal tract in the pathogenesis of spondyloartropathies
is well defined and many studies underline the importance
of gastrointestinal inflammation in modulating local and
systemic inflammation, the data are inconclusive regarding the
effect of dysbiosis on rheumatoid arthritis and connective tissue
diseases. This review aims to summarize current data on the role
of the gastrointestinal involvement and intestinal microbiota in
the pathogenesis of systemic rheumatic disease